Showing 1281-1290 of 2989 results for "".
Treatment Options for Cranial Neuralgias
https://practicalneurology.com/diseases-diagnoses/headache-pain/treatment-options-for-cranial-neuralgias/30465/A review of treatment and coding options for various cranial neuralgias.Case Report: Cyclophosphamide as Rescue Agent in Myasthenic Crisis
https://practicalneurology.com/diseases-diagnoses/neuromuscular/case-report-cyclophosphamide-as-rescue-agent-in-myasthenic-crisis/30120/When patients are refractory to first-line treatments for myasthenic crisis, cyclophosphamide may have benefits and warrants further study.Dementia Insights: Blood Pressure Control and Cognitive Impairment
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/dementia-insights-blood-pressure-control-and-cognitive-impairment/30151/Could recommendations for more aggressive blood pressure control worsen prognosis for vascular and neurodegenerative cognitive impairments?Advancements in MS Therapy
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/advancements-in-ms-therapy/30862/New oral agents—approved and in the pipeline—may instigate an evolution in the treatment of MS.- When the Problem is the Patient: How to Handle Bothersome Behaviorhttps://practicalneurology.com/columns/practice-management/when-the-problem-is-the-patient-how-to-handle-bothersome-behavior/31231/In the January 2007 issue of Practical Neurology, Dr. Randolph W. Evans highlights a significant yet under-discussed issue within the medical community: bothersome patient behaviors as reported by neurologists. Motivated by a 2005 New York Times article where patients criticized physicians for being
- From Exam Room to Board Roomhttps://practicalneurology.com/columns/practice-management/from-exam-room-to-board-room/31418/Pharmaceutical Consulting Opportunities for NeurologistsIn recent years, many private neurologists have increasingly collaborated with pharmaceutical companies, driven by factors such as frustration with third-party payers, advancements in clinical innovations, and the blurred lines between clinical
- Defensive Medicine: Is It Putting Barriers Between You and Your Patients?https://practicalneurology.com/columns/practice-management/defensive-medicine-is-it-putting-barriers-between-you-and-your-patients/31341/Defensive Medicine in Neurology: Balancing Patient Care and Malpractice RisksRising malpractice liabilities are compelling neurologists to adopt defensive medicine practices, significantly impacting patient care and escalating healthcare costs. In a February 2006 issue of *Practical Neurology*, Asso
- Bringing in the Bucks with Botoxhttps://practicalneurology.com/diseases-diagnoses/headache-pain/pn0205pg37-40-pdf/31492/Botulinum toxin A (Botox), since its FDA approval in 1989, has become a valuable tool for neurologists, enhancing patient care while contributing to practice revenue. Its approved uses include treating cervical dystonia, intractable migraines, facial nerve disorders, spasmodic dysphonia, hyperhidros
- Editor's Messagehttps://practicalneurology.com/columns/practice-management/editors-message/31293/Practical Neurology’s Esteemed Editorial and Contributing Boards Showcase Leading Expertise in Neurological MedicinePractical Neurology proudly features a distinguished team of medical professionals serving on its Editorial Advisory Board, Editorial Board, and as Contributing Editors. This collectiv
Neuromuscular Notes: Genetics of Amyotrophic Lateral Sclerosis
https://practicalneurology.com/diseases-diagnoses/neuromuscular/neuromuscular-notes-genetics-of-amyotrophic-lateral-sclerosis/31522/Genetic discovery and the promise of gene therapy create hope for effective treatments and eventual prevention.